{
  "generated": "2025-11-05T08:53:28.547967+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/nutraceutical/red-yeast-rice-card-redy-statin/cardiovascular/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "CARD-REDY-STATIN_01",
      "year": 2022,
      "design": "randomized controlled trial",
      "journal": "cardiovascular_journal",
      "outcome": "cholesterol",
      "population": "Adults with hyperlipidemia",
      "adverse_events": "Transient headache",
      "doi": "10.3389/fphar.2022.744928",
      "url": "https://doi.org/10.3389/fphar.2022.744928",
      "citation": "CARD-REDY-STATIN_01 (2022); Journal: cardiovascular_journal; Design: randomized controlled trial; Population: Adults with hyperlipidemia; Outcome: cholesterol; DOI: 10.3389/fphar.2022.744928; Adverse Events: Transient headache."
    },
    {
      "study_id": "CARD-REDY-STATIN_02",
      "year": 2022,
      "design": "randomized controlled trial",
      "journal": "cardiovascular_journal",
      "outcome": "cholesterol",
      "population": "Adults with hyperlipidemia",
      "adverse_events": "Transient headache",
      "doi": "10.3389/fphar.2022.917521",
      "url": "https://doi.org/10.3389/fphar.2022.917521",
      "citation": "CARD-REDY-STATIN_02 (2022); Journal: cardiovascular_journal; Design: randomized controlled trial; Population: Adults with hyperlipidemia; Outcome: cholesterol; DOI: 10.3389/fphar.2022.917521; Adverse Events: Transient headache."
    },
    {
      "study_id": "CARD-REDY-STATIN_03",
      "year": 2020,
      "design": "randomized controlled trial",
      "journal": "cardiovascular_journal",
      "outcome": "cholesterol",
      "population": "Adults with hyperlipidemia",
      "adverse_events": "Transient headache",
      "doi": "10.1038/s41598-020-59796-5",
      "url": "https://doi.org/10.1038/s41598-020-59796-5",
      "citation": "CARD-REDY-STATIN_03 (2020); Journal: cardiovascular_journal; Design: randomized controlled trial; Population: Adults with hyperlipidemia; Outcome: cholesterol; DOI: 10.1038/s41598-020-59796-5; Adverse Events: Transient headache."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1038/s41598-020-59796-5",
      "study_ids": [
        "CARD-REDY-STATIN_03"
      ],
      "primary_study_id": "CARD-REDY-STATIN_03",
      "url": "https://doi.org/10.1038/s41598-020-59796-5"
    },
    {
      "type": "doi",
      "identifier": "10.3389/fphar.2022.744928",
      "study_ids": [
        "CARD-REDY-STATIN_01"
      ],
      "primary_study_id": "CARD-REDY-STATIN_01",
      "url": "https://doi.org/10.3389/fphar.2022.744928"
    },
    {
      "type": "doi",
      "identifier": "10.3389/fphar.2022.917521",
      "study_ids": [
        "CARD-REDY-STATIN_02"
      ],
      "primary_study_id": "CARD-REDY-STATIN_02",
      "url": "https://doi.org/10.3389/fphar.2022.917521"
    }
  ],
  "manifest_hash": "sha256:7840d38464fe4e280b26c0b12072c4c78754bbea467601cb7e863d458010ff76"
}
